Ghent University Academic Bibliography

Journal Article
A1
open access

The role of miR-320d in regulation of cigarette smoke-induced pro-inflammatory responses in COPD

Mirjam Roffel, Corry-Anke Brandsma, Alen Faiz, Marnix R Jonker, Wim Timens, Guy Joos (UGent) , Guy Brusselle (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Maarten van den Berge, et al.

(2026) ARCHIVOS DE BRONCONEUMOLOGIA. 62(2). p.86-93

Add to list

Journal Article
A1
open access

Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma : a systematic review

Helena Catharine Aegerter (UGent) , Christopher E. Brightling, Eleanor M. Dunican, Bart Lambrecht (UGent) , Njira L. Lugogo, John D. Newell, Celeste Porsbjerg, Sarah Svenningsen, Deborah Clarke, Andrew W. Lindsley, et al.

(2026) RESPIRATORY RESEARCH. 27(1).

Add to list

Journal Article
A1
open access

Real-world adherence to asthma and COPD medications in Belgium : a nationwide analysis of determinants using dispensing data and mixed-effects modeling

Amélie Rosière, Sebastian Riemann (UGent) , Olfa Guaddoudi, Stéphanie Pochet, Guy Brusselle (UGent) and Carine De Vriese

(2026) HEALTHCARE. 14(8).

Add to list

Journal Article
A1
open access

Update on the pathogenetic hallmarks of chronic obstructive pulmonary disease

Ken Bracke (UGent) and Guy Brusselle (UGent)

(2026) PRESSE MEDICALE. 55(1).

Add to list

Journal Article
A1
open access

BDP/FF/GB single-inhaler triple therapy in COPD : real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients

Guy Brusselle (UGent) , Petros Bakakos, Daiana Stolz, Alessio Piraino, Laura Franzini, Elena Nudo, Luca Di Palma and Paola Rogliani

(2026) RESPIRATORY MEDICINE. 254.

Add to list

Validation of the late-life function and disability instrument in people living with chronic obstructive pulmonary disease : a clinical trial

Astrid Blondeel, Heleen Demeyer (UGent) , Victoria Alcaraz-Serrano, Sara C Buttery, Joren Buekers, Nikolaos Chynkiamis, Alícia Josa-Culleré, Laura Delgado-Ortiz, Anja Frei, Lies Glorie, et al.

(2025) ANNALS OF THE AMERICAN THORACIC SOCIETY. 22(1). p.72-82

Add to list

Journal Article
A1
open access

Impact of respiratory and cardiovascular drug exposure on lung function trajectories

Xander Bertels (UGent) , Delphine Vauterin (UGent) , Sebastian Riemann (UGent) , Frauke Van Vaerenbergh (UGent) , Kristiaan Proesmans (UGent) , André G. Uitterlinden, M. Arfan Ikram, Guy Brusselle (UGent) , Bruno H. Stricker and Lies Lahousse (UGent)

(2025) ANNALS OF THE AMERICAN THORACIC SOCIETY. 22(1). p.54-63

Add to list

Journal Article
A1
open access

Association of timely spirometry with lower all-cause mortality

Valerie Dehondt (UGent) , Delphine Vauterin (UGent) , Eric Derom (UGent) and Lies Lahousse (UGent)

(2025) CHEST. 168(3). p.602-612

Add to list

Journal Article
A1
open access

Real-life impact of anti-IL5 therapy on exacerbation types in patients with obstructive lung disease

Lowie Vanfleteren (UGent) , Delphine Vauterin (UGent) and Lies Lahousse (UGent)

(2025) BMJ OPEN RESPIRATORY RESEARCH. 12(1).

Add to list

Journal Article
A1
open access

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases

Delphine Vauterin (UGent) , Frauke Van Vaerenbergh (UGent) , Maxim Grymonprez (UGent) , Guy Joos (UGent) and Lies Lahousse (UGent)

(2025) ERJ OPEN RESEARCH. 11(5).

Academic Bibliography

The role of miR-320d in regulation of cigarette smoke-induced pro-inflammatory responses in COPD

Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma : a systematic review

Real-world adherence to asthma and COPD medications in Belgium : a nationwide analysis of determinants using dispensing data and mixed-effects modeling

Update on the pathogenetic hallmarks of chronic obstructive pulmonary disease

BDP/FF/GB single-inhaler triple therapy in COPD : real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients

Validation of the late-life function and disability instrument in people living with chronic obstructive pulmonary disease : a clinical trial

Impact of respiratory and cardiovascular drug exposure on lung function trajectories

Association of timely spirometry with lower all-cause mortality

Real-life impact of anti-IL5 therapy on exacerbation types in patients with obstructive lung disease

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases

Contents

Support

Contact